Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Cash Flow Quality Index
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Quality Index of 2.55x as of March 2025. Operating cash flow of CN¥39.75 Million exceeds net income of CN¥15.58 Million, indicating high earnings quality where cash backs reported profits. Explore 688488 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2020)
Historical Cash Flow Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Jiangsu Aidea Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Year-by-year earnings quality comparison for Jiangsu Aidea Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.41x | CN¥56.17 Million | CN¥39.77 Million | ▼ -15.4% |
| 2019 | 1.67x | CN¥56.20 Million | CN¥33.65 Million | ▲ +143.0% |
| 2018 | -3.89x | CN¥-33.50 Million | CN¥8.62 Million | ▼ -276.9% |
| 2016 | 2.20x | CN¥31.29 Million | CN¥14.24 Million | — |